NO944689L - Imidazopyrider - Google Patents

Imidazopyrider

Info

Publication number
NO944689L
NO944689L NO944689A NO944689A NO944689L NO 944689 L NO944689 L NO 944689L NO 944689 A NO944689 A NO 944689A NO 944689 A NO944689 A NO 944689A NO 944689 L NO944689 L NO 944689L
Authority
NO
Norway
Prior art keywords
imidazopyrider
nistic
char1
aldosteronism
properties
Prior art date
Application number
NO944689A
Other languages
English (en)
Other versions
NO944689D0 (no
Inventor
Werner Mederski
Dieter Dorsch
Mathias Osswald
Norbert Beier
Pierre Schelling
Klaus-Otto Minck
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO944689D0 publication Critical patent/NO944689D0/no
Publication of NO944689L publication Critical patent/NO944689L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye imidazopyridinderivater med formel I R-CH hvor betyr N R4 N-CHAr1-CO-R3 og R1, R2, R3, R4, Ar1, X og Y har de i krav l angitte betydninger, samt salter derav, utviser angiotensin II-antago- nistiske egenskaper og kan anvendes til behandling av hypertensjon, aldostero- nisme, hjerteinsuffisiens og forhøyet øyeinnertrykk, samt av forstyrrelser i sentralnervesystemet.
NO944689A 1993-12-06 1994-12-05 Imidazopyrider NO944689L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341453A DE4341453A1 (de) 1993-12-06 1993-12-06 Imidazopyridine

Publications (2)

Publication Number Publication Date
NO944689D0 NO944689D0 (no) 1994-12-05
NO944689L true NO944689L (no) 1995-06-07

Family

ID=6504241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944689A NO944689L (no) 1993-12-06 1994-12-05 Imidazopyrider

Country Status (16)

Country Link
US (1) US5532276A (no)
EP (1) EP0657452A1 (no)
JP (1) JPH07196656A (no)
KR (1) KR950018006A (no)
CN (1) CN1109056A (no)
AU (1) AU7919094A (no)
CA (1) CA2137213A1 (no)
CZ (1) CZ304694A3 (no)
DE (1) DE4341453A1 (no)
HU (1) HUT72595A (no)
NO (1) NO944689L (no)
PL (1) PL306127A1 (no)
RU (1) RU94042907A (no)
SK (1) SK149294A3 (no)
TW (1) TW294665B (no)
ZA (1) ZA949664B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798364A (en) * 1992-03-26 1998-08-25 Merck Patent Gesellschaft Mit Beschrankter Haftung Imidazopyridines
US6348380B1 (en) * 2000-08-25 2002-02-19 Micron Technology, Inc. Use of dilute steam ambient for improvement of flash devices
GEP20063937B (en) * 2002-02-14 2006-10-10 Pharmacia Corp Substituted pyridinones as modulators of p38 map kinase
ES2270143T3 (es) * 2002-08-07 2007-04-01 Novartis Ag Compuestos organicos como agentes para el tratamiento de condiciones mediadas por aldosterona.
CN1894234A (zh) 2003-03-25 2007-01-10 武田药品工业株式会社 二肽基肽酶抑制剂
MXPA06001601A (es) 2003-08-13 2006-08-25 Takeda Pharmaceutical Derivados de 4-pirimidona y su uso como inhibidores de dipeptidilpeptidasa.
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2005026148A1 (en) 2003-09-08 2005-03-24 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102079743B (zh) 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
WO2005118555A1 (en) 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
MX2007002178A (es) 2004-08-23 2007-04-02 Wyeth Corp Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
US7186749B2 (en) 2004-08-23 2007-03-06 Wyeth Pyrrolo-naphthyl acids and methods for using them
CN101044127A (zh) 2004-08-23 2007-09-26 惠氏公司 用作纤溶酶原激活剂抑制剂－1的噻唑基－萘基酸
WO2006068978A2 (en) 2004-12-21 2006-06-29 Takeda Pharmaceutial Company Limited Dipeptidyl peptidase inhibitors
WO2007033350A1 (en) 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
EP1924567B1 (en) 2005-09-16 2012-08-22 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
JP5627453B2 (ja) * 2008-03-31 2014-11-19 株式会社レナサイエンス プラスミノーゲンアクチベーターインヒビター−１阻害剤
KR101762574B1 (ko) 2009-03-31 2017-07-28 가부시키가이샤 레나사이언스 플라즈미노겐 액티베이터 인히비터-1 저해제
US10092537B2 (en) 2013-04-15 2018-10-09 Renascience Co., Ltd. Use for PAI-1 inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
DE4141788A1 (de) * 1991-12-18 1993-06-24 Merck Patent Gmbh Imidazopyridine
DE4208304A1 (de) * 1992-03-16 1993-09-23 Merck Patent Gmbh 2-oxochinolinderivate
DE4211474A1 (de) * 1992-04-06 1993-10-07 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine
DE4225835A1 (de) * 1992-08-05 1994-02-10 Merck Patent Gmbh Verfahren zur Herstellung von Imidazopyridinen
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
RU94042907A (ru) 1996-10-20
CZ304694A3 (en) 1995-08-16
US5532276A (en) 1996-07-02
AU7919094A (en) 1995-06-15
HUT72595A (en) 1996-05-28
EP0657452A1 (de) 1995-06-14
SK149294A3 (en) 1995-07-11
HU9403451D0 (en) 1995-02-28
CN1109056A (zh) 1995-09-27
NO944689D0 (no) 1994-12-05
PL306127A1 (en) 1995-06-12
DE4341453A1 (de) 1995-06-08
TW294665B (no) 1997-01-01
JPH07196656A (ja) 1995-08-01
ZA949664B (en) 1995-08-15
CA2137213A1 (en) 1995-06-07
KR950018006A (ko) 1995-07-22

Similar Documents

Publication Publication Date Title
NO944689L (no) Imidazopyrider
NO942095L (no) Imidazopyridiner
DK0737194T3 (da) Diazabicykliske neurokininantagonister
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
MY121967A (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
PL326702A1 (en) Cyclic and heterocyclic n-substituted derivatives of alpha-iminohydroxamic and carboxylic acids
NO20002702L (no) Tienopyrimidiner
ATE194593T1 (de) 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
NO178262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler
DE60027769D1 (de) Pyrrolidin-derivate als inhibitoren von cyclischer amp-phosphodiesterase
DE69715862T2 (de) Verwendung eines k-252a derivats zur behandlung von periphärer oder zentraler nervenerkrankungen und übermässiger cytokinbildung
FI965021A (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
DE69118198T2 (de) Substituierte tetrahydropyridine und hydroxypiperidine als mittel zur behandlung des zentralen nervensystems
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
NZ314570A (en) Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
MX9306563A (es) Derivados de imidazopiridinas, proceso para su preparacion y formulaciones farmaceuticas que los contienen.
NO943791L (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
NO20012538L (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
NO20021310L (no) Aminderivater
RU93048331A (ru) Имидазопиридины, способ их получения, фармацевтическая композиция и способ ее получения, способ лечения
NO970498L (no) Benzimidazolderivater med dopaminergisk aktivitet